Q&A: Forbion Capital Partners' Sander Slootweg
Life-sciences-focused venture firm Forbion Capital Partners recently held a €360m final close for its fourth flagship fund, surpassing its initial hard-cap of €350m. Managing partner Sander Slootweg speaks to Francesca Veronesi about the fundraising process, the firm's 'build' strategy and the European life sciences venture market
More on Benelux
VCs in €20m series-B for PDCLine
In 2016, Belgian VC Meusinvest, Spinventure and several business angels invested €4m in the company
PAI Partners to launch €600m mid-market fund
Vehicle will target companies based across Italy, Spain, Germany, France and the Benelux region
Unquote Private Equity Podcast: the Review/Preview special
In this special bumper episode, the Unquote editorial team does a deep dive on key 2019 stats in each market
Ergon Capital Partners to back CompaNanny
Belgian GP plans to back the company, according to a document by the Dutch competition authority
Latest News
NYSCRF backs secondary special situations fund
New York State Common Retirement Fund (NYSCRF) has committed $400m to secondary special situations and new private lending investments in Asia-Pacific, according to documents seen by Unquote.
Avallon holds €80.6m first closing for third fund
Fund completed its first deal, backing Poland-based household cleaning products manufacturer Clovin
BD-Capital appoints Vidal-Quadras as head of southern Europe
BD-Capital is a recently established private equity firm targeting European mid-market businesses
Ouest Croissance, Multicroissance back Idaia Group
GPs invest in the business alongside the founder Barbier and the management team led by Maderay